Safety of High-Dose 3% Sodium Tetradecyl Sulfate for Sclerothe | Radiation Oncology | Articles preview
Safety of High-Dose 3% Sodium Tetradecyl Sulfate for Sclerotherapy of Renal Cysts in Patients with Autosomal Dominant Polycystic Kidney Disease https://www.jvir.org/article/S1051-0443(22)00107-5/fulltext?rss=yes
This study assessed the safety profile of high-volume (>10 mL) 3% sodium tetradecyl sulfate (STS) sclerotherapy for the treatment of renal cysts in patients with autosomal dominant polycystic kidney disease. A total of 211 sclerotherapy treatments were performed in 169 patients over a 5-year period, with a comparison of 2 patient cohorts based on the STS volumes used. The first cohort (n = 112) received a high volume (greater than 10 mL) of STS, and the second cohort (n = 57) received a low volume (less than 10 mL).
We publish the latest articles on Radiation Oncology from popular sites. @TON4U - take some Toncoin . Literature:. @MedPhysLib | @RadLib | @RadiologyGoldenBooks . Admin: . @negotiatorbot...